| ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients A Wollenberg, A Oranje, M Deleuran, D Simon, Z Szalai, B Kunz, ... Journal of the European Academy of Dermatology and Venereology 30 (5), 729-747, 2016 | 524 | 2016 |
| Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells J Seneschal, RA Clark, A Gehad, CM Baecher-Allan, TS Kupper Immunity 36 (5), 873-884, 2012 | 508 | 2012 |
| ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children A Wollenberg, S Christen‐Zäch, A Taieb, C Paul, JP Thyssen, ... Journal of the European Academy of Dermatology and Venereology 34 (12), 2717 …, 2020 | 304 | 2020 |
| Vitiligo: focus on clinical aspects, immunopathogenesis, and therapy K Boniface, J Seneschal, M Picardo, A Taïeb Clinical reviews in allergy & immunology 54, 52-67, 2018 | 252 | 2018 |
| Platelet CD154 potentiates interferon-α secretion by plasmacytoid dendritic cells in systemic lupus erythematosus P Duffau, J Seneschal, C Nicco, C Richez, E Lazaro, I Douchet, C Bordes, ... Science translational medicine 2 (47), 47ra63-47ra63, 2010 | 239 | 2010 |
| OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response C Jacquemin, N Schmitt, C Contin-Bordes, Y Liu, P Narayanan, ... Immunity 42 (6), 1159-1170, 2015 | 232 | 2015 |
| European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes R Knobler, P Moinzadeh, N Hunzelmann, A Kreuter, A Cozzio, L Mouthon, ... Journal of the European Academy of Dermatology and Venereology 31 (9), 1401-1424, 2017 | 224 | 2017 |
| Vitiligo skin is imprinted with resident memory CD8 T cells expressing CXCR3 K Boniface, C Jacquemin, AS Darrigade, B Dessarthe, C Martins, ... Journal of Investigative Dermatology 138 (2), 355-364, 2018 | 195 | 2018 |
| Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort S Faiz, J Giovannelli, C Podevin, M Jachiet, JD Bouaziz, Z Reguiai, ... Journal of the American Academy of Dermatology 81 (1), 143-151, 2019 | 184 | 2019 |
| Cytokine imbalance with increased production of interferon‐α in psoriasiform eruptions associated with antitumour necrosis factor‐α treatments J Seneschal, B Milpied, B Vergier, S Lepreux, T Schaeverbeke, A Taïeb British Journal of Dermatology 161 (5), 1081-1088, 2009 | 176 | 2009 |
| Vitiligo-like lesions occurring in patients receiving anti-programmed cell death–1 therapies are clinically and biologically distinct from vitiligo M Larsabal, A Marti, C Jacquemin, J Rambert, D Thiolat, L Dousset, ... Journal of the American Academy of Dermatology 76 (5), 863-870, 2017 | 149 | 2017 |
| Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case–control study D Laharie, J Seneschal, T Schaeverbeke, MS Doutre, M Longy-Boursier, ... Journal of hepatology 53 (6), 1035-1040, 2010 | 133 | 2010 |
| European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) infection and atopic dermatitis A Wollenberg, C Flohr, D Simon, MJ Cork, JP Thyssen, T Bieber, ... Journal of the European Academy of Dermatology and Venereology 34 (6), e241-e242, 2020 | 132 | 2020 |
| Type I interferon signature in the initiation of the immune response in vitiligo A Bertolotti, K Boniface, B Vergier, D Mossalayi, A Taieb, K Ezzedine, ... Pigment cell & melanoma research 27 (3), 398-407, 2014 | 132 | 2014 |
| Imatinib mesylate in scleroderma‐associated diffuse skin fibrosis: a phase II multicentre randomized double‐blinded controlled trial S Prey, K Ezzedine, A Doussau, AS Grandoulier, D Barcat, E Chatelus, ... British Journal of Dermatology 167 (5), 1138-1144, 2012 | 120 | 2012 |
| European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period C Vestergaard, A Wollenberg, S Barbarot, S Christen‐Zaech, M Deleuran, ... Journal of the European Academy of Dermatology and Venereology 33 (9), 1644-1659, 2019 | 114 | 2019 |
| European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis R Knobler, P Moinzadeh, N Hunzelmann, A Kreuter, A Cozzio, L Mouthon, ... Journal of the European Academy of Dermatology and Venereology 31 (10), 1581 …, 2017 | 112 | 2017 |
| The vitiligo impact patient scale (VIPs): development and validation of a vitiligo burden assessment tool C Salzes, S Abadie, J Seneschal, M Whitton, JM Meurant, T Jouary, ... Journal of Investigative Dermatology 136 (1), 52-58, 2016 | 105 | 2016 |
| Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms A Gey, A Diallo, J Seneschal, C Léauté‐Labrèze, F Boralevi, T Jouary, ... British Journal of Dermatology 168 (4), 756-761, 2013 | 96 | 2013 |
| Loss of epidermal hypoxia-inducible factor-1α accelerates epidermal aging and affects re-epithelialization in human and mouse HR Rezvani, N Ali, M Serrano-Sanchez, P Dubus, C Varon, C Ged, ... Journal of cell science 124 (24), 4172-4183, 2011 | 96 | 2011 |
